Hongyun Huang

Beijing, 100143, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Retraction Note: Cerebrolysin Attenuates Exacerbation of Neuropathic Pain, Blood-Spinal Cord Barrier Breakdown and Cord Pathology Following Chronic Intoxication of Engineered Ag, Cu or Al (50-60 nm) Nanoparticles.

Retraction Note: Cerebrolysin Attenuates Exacerbation of Neuropathic Pain, Blood-Spinal Cord Barrier Breakdown and Cord Pathology Following Chronic Intoxication of Engineered Ag, Cu or Al (50-60 nm) Nanoparticles.

Journal: Neurochemical research

Published: May 16, 2026

Retraction Notice to " Therapeutic application of gene silencing MMP-9 in a middle cerebral artery occlusion-induced focal ischemia rat model" [Experimental Neurology 216 (2009) 35-46].

Retraction Notice to " Therapeutic application of gene silencing MMP-9 in a middle cerebral artery occlusion-induced focal ischemia rat model" [Experimental Neurology 216 (2009) 35-46].

Journal: Experimental neurology

Published: March 07, 2026

Neurorestorative therapeutic strategies for sequela of central nervous system infections.

Neurorestorative therapeutic strategies for sequela of central nervous system infections.

Journal: Infectious medicine

Published: September 20, 2024

Co-administration of dl-3-n-butylphthalide and neprilysin is neuroprotective in Alzheimer disease associated with mild traumatic brain injury.

Co-administration of dl-3-n-butylphthalide and neprilysin is neuroprotective in Alzheimer disease associated with mild traumatic brain injury.

Journal: International review of neurobiology

Published: October 13, 2023

Positive and negative cell therapy in randomized control trials for central nervous system diseases.

Positive and negative cell therapy in randomized control trials for central nervous system diseases.

Journal: International review of neurobiology

Published: October 02, 2023

Susac syndrome can be diagnosed by examination and cured by comprehensive therapy.

Susac syndrome can be diagnosed by examination and cured by comprehensive therapy.

Journal: International review of neurobiology

Published: October 02, 2023

Nose-to-brain drug delivery for the treatment of CNS disease: New development and strategies.

Nose-to-brain drug delivery for the treatment of CNS disease: New development and strategies.

Journal: International review of neurobiology

Published: October 02, 2023

Advances in Neurorestoratology-Current status and future developments.

Advances in Neurorestoratology-Current status and future developments.

Journal: International review of neurobiology

Published: October 02, 2023

Nanowired delivery of dl-3-n-butylphthalide with antibodies to alpha synuclein potentiated neuroprotection in Parkinson's disease with emotional stress.

Nanowired delivery of dl-3-n-butylphthalide with antibodies to alpha synuclein potentiated neuroprotection in Parkinson's disease with emotional stress.

Journal: International review of neurobiology

Published: October 02, 2023

Neuroprotective Effects of Nanowired Delivery of Cerebrolysin with Mesenchymal Stem Cells and Monoclonal Antibodies to Neuronal Nitric Oxide Synthase in Brain Pathology Following Alzheimer's Disease Exacerbated by Concussive Head Injury.

Neuroprotective Effects of Nanowired Delivery of Cerebrolysin with Mesenchymal Stem Cells and Monoclonal Antibodies to Neuronal Nitric Oxide Synthase in Brain Pathology Following Alzheimer's Disease Exacerbated by Concussive Head Injury.

Journal: Advances in neurobiology

Published: July 22, 2023

Nanodelivery of Histamine H3/H4 Receptor Modulators BF-2649 and Clobenpropit with Antibodies to Amyloid Beta Peptide in Combination with Alpha Synuclein Reduces Brain Pathology in Parkinson's Disease.

Nanodelivery of Histamine H3/H4 Receptor Modulators BF-2649 and Clobenpropit with Antibodies to Amyloid Beta Peptide in Combination with Alpha Synuclein Reduces Brain Pathology in Parkinson's Disease.

Journal: Advances in neurobiology

Published: July 22, 2023

Clinical results of neurorestorative cell therapies and therapeutic indications according to cellular bio-proprieties.

Clinical results of neurorestorative cell therapies and therapeutic indications according to cellular bio-proprieties.

Journal: Regenerative therapy

Published: January 26, 2023

Showing 1-12 of 40

Last Updated: 09/26/2026